BIO announces Everyday Superhero honorees.

Press Release Summary:



The 2015 BIO International Convention announced top Honorees in association's Everyday Superhero contest, recognizing biotech leaders in the patient, industry, and academic communities whose accomplishments are helping those battling debilitating and chronic disease. Top honorees chosen from Patient/Patient Group, Pharma/Biotech, and University Research Institutions include Emily Whitehead, Bernard Muller, and Sanjay Balkrishna Jadhao, respectively.



Original Press Release:



BIO 2015 International Convention Everyday Superhero Honorees Announced



Recognizing Biotech Champions in the Patient, Industry and Academic Communities



WASHINGTON -- Today, the 2015 BIO International Convention announced the top Honorees in the association’s Everyday Superhero contest, recognizing biotech leaders in the patient, industry and academic communities whose accomplishments are helping those battling debilitating and chronic disease. Honorees were chosen from one of three categories: Patient/Patient Group, Pharma/Biotech and University Research Institutions.



“The biotechnology industry is filled with countless superheroes—they are the inspiring patients, academics and industry researchers like the individuals who we are proud to honor today”

“The biotechnology industry is filled with countless superheroes—they are the inspiring patients, academics and industry researchers like the individuals who we are proud to honor today,” said BIO President and CEO Jim Greenwood. “These real everyday superheroes have helped to advance groundbreaking new therapies and technologies. We are thankful to all of our nominees and their unwavering dedication to using biotechnology to heal, feed and fuel the world.”



Patient/Patient Group Category



The Patient/Patient Group Category recognizes individuals who have raised awareness for a specific patient community through their own personal journey or advocacy efforts.



Top Honoree: Emily Whitehead, Acute Lymphoblastic Leukemia Survivor. At only six years old, Emily was diagnosed with Acute Lymphoblastic Leukemia, and after several years of treatment, her family was told they were out of options. As a final hope, Emily was enrolled in an immunotherapy clinical trial where she became the first pediatric patient to receive genetically modified T-cells that were trained to identify and kill cancer cells. The treatment worked and her story made national headlines. The news helped focus public attention on the potential for immunotherapy to transform cancer treatment and the importance of supporting lifesaving cancer research.



Pharma/Biotech Category



The Pharma/Biotech Category recognizes employees in the life science industry who have been instrumental in advancing therapies for patients.



Top Honoree: Bernard Muller, Founder & Chief Business Officer, Treeway. Bernard calls himself Patient 3.0. He was diagnosed with ALS and took it as a challenge. In 2012, he co-founded the world’s largest genetic research project for ALS, project MinE. That same year, he also launched a biotech company with the aim of finding a cure or therapy for ALS. His company, Treeway, is now entering Phase 3 clinical trials with its lead product candidate.



University/Research Institutions Category



The University/Research Institutions Category recognizes researchers or scientists in academia who have been instrumental in researching or advancing therapies for patients.



Top Honoree: Sanjay Balkrishna Jadhao, Associate Professor and Senior Scientist, Central Institute of Fisheries Education Mumbai. An expert in agriculture, animals and aquaculture, Sanjay has made it his mission to help India’s undernourished population, approximately 190 million people, by transforming the food and agriculture ecosystem.



The top honorees were chosen by a majority vote and announced during the keynote at BIO’s 2015 International Convention. You can find out more about them by visiting http://convention.bio.org/superhero.



About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.



Upcoming BIO Events



BIO International Convention

June 15-18, 2015

Philadelphia, PA



World Congress on Industrial Biotechnology

July 19-22, 2015

Montréal, Canada



BIO Latin America Conference

October 14-16, 2015

Rio de Janeiro, Brazil



BIO Investor Forum

October 20-21, 2015

San Francisco, CA



Contacts

Biotechnology Industry Organization (BIO)

Daniel Seaton, 202-470-5207

Web: www.bio.org

Blog: www.biotech-now.org

Twitter: @IAmBiotech

All Topics